Dg. Mcintosh et al., THE INTRAOPERATIVE DETECTION OF OVARIAN ADENOCARCINOMA USING RADIOLABELED CC49 MONOCLONAL-ANTIBODY AND A HAND-HELD GAMMA-DETECTING PROBE, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(4), 1997, pp. 287-294
A phase II study to evaluate the safety and efficacy of the I-125-radi
olabeled anti-TAG-72 monoclonal antibody, CC49, as a component of a sy
stem for the intraoperative detection of occult ovarian cancer deposit
s was carried out at the University of Nebraska Medical Center. Patien
ts entered into the,study were to have surgery for evaluation of their
disease status. The primary objective of this study was to determine
the ability of a gamma-detecting probe (GDP), the Neoprobe(R)1000, to
intraoperatively localize sites of disease not identified by tradition
al surgical or radiographic evaluation. It was postulated that improve
d detection of cancer foci might allow for therapeutic excision or mig
ht result in an alteration of subsequent treatment. Ten patients were
enrolled in the study between May 1993 and March 1994. Nine of the pat
ients were undergoing second-look surgery after completing primary che
motherapy. The remaining patient was having surgery to assess possible
cancer recurrence All patients received an intravenous injection of 2
mCi/1mg I-125-radiolabeled CC49 without complication. After a mean of
24.5 days. the patients' background radiation counts were deemed low e
nough for accurate intraoperative cancer localization, and surgery was
performed Anl, visibly or palpably abnormal areas were biopsied after
being evaluated with the GDP. Arty areas suspicious for malignancy by
GDP evaluation were also biopsied. Two patients without evident disea
se by radiographic or surgical examination had histologically confirme
d metastases localized by the GDP. Four patients had obvious disease a
t surgery which was variably confirmed by the GDP; two of these patien
ts had baseline elevations in circulating TAG-72 antigen levels that m
ay have affected binding of antibody to the tumor. This system of radi
oimmunoguided surgery was well tolerated and practical in its applicat
ion, and it permitted disease detection that resulted in potentially b
eneficial changes in patient management.